Skip to content

Effectiveness of routine Risk Assessment and Care Evaluation (RACE) in violence prevention in outpatient forensic psychiatry; a randomized clinical trial

Effectiveness of routine Risk Assessment and Care Evaluation (RACE) in violence prevention in outpatient forensic psychiatry; a randomized clinical trial - RACE (Risk Assessment and Care Evaluation) study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON30556
Enrollment
680
Registered
2007-08-21
Start date
2007-05-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

behavioral disorders mental disorders

Interventions

In the experimental group routine risk assessment and care evaluation is carried out at every formal evaluation of the care plan, but at least once every six months. This consists of (1) an assessme

Sponsors

GGZ Drenthe (Assen)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Clients of outpatient forensic psychiatric services, who are expected to remain in care for another six months or more

Exclusion criteria

Exclusion criteria: Less than one contact a month with the outpatient forensic psychiatric service, on average

Design outcomes

Primary

MeasureTime frame
Primary outcome is the proportion of clients showing *violent behaviour* (including criminal behaviour, physical violence, and verbal aggression) in the six moths prior to follow-up (at 18 months or end or treatment). Information on violent behaviour is gathered in two ways. First, by continuous registration of violent incidents by the case manager, as part of the medical record of clients in both research conditions. And second, by self-report in the follow-up interview. Any reports of a violent incident is judged by a panel of forensic psychiatric experts, who will be *blind* about the research condition of the client, as will be the interviewers.

Secondary

MeasureTime frame
Secondary outcomes are *risk enhancing behaviour* (e.g. breaking of agreements, stopping necessary medication, drug abuse), quality of life, psychiatric and social functioning, aggression, impulsivity, and satisfaction with care and the therapeutic relation.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)